Context-Dependent Modulation of GABAAR-Mediated Tonic Currents by Patel, B et al.
Cellular/Molecular
Context-Dependent Modulation of GABAAR-Mediated
Tonic Currents
Bijal Patel,1 Damian P. Bright,1 Martin Mortensen,1 Bente Frølund,2 and Trevor G. Smart1
1Department of Neuroscience, Physiology, and Pharmacology, University College London, LondonWC1E 6BT, United Kingdom, and 2Faculty of Health and
Medical Sciences, Medicinal Chemistry Research, University of Copenhagen, Jagtvej 162, 2100 Copenhagen Ø, Denmark
Tonic GABA currents mediated by high-affinity extrasynaptic GABAA receptors, are increasingly recognized as important regulators of
cell and neuronal network excitability. Dysfunctional GABAA receptor signaling that results in modified tonic GABA currents is associ-
atedwith a number of neurological disorders. Consequently, developing compounds to selectivelymodulate the activity of extrasynaptic
GABAA receptors underlying tonic inhibition is likely to prove therapeutically useful. Here, we examine the GABAA receptor subtype
selectivity of the weak partial agonist, 5-(4-piperidyl)isoxazol-3-ol (4-PIOL), as a potential mechanism for modulating extrasynaptic
GABAA receptor-mediated tonic currents. By using recombinant GABAA receptors expressed in HEK293 cells, and native GABAA recep-
tors of cerebellar granule cells, hippocampal neurons, and thalamic relay neurons, 4-PIOL evidently displayed differential agonist and
antagonist-type profiles, depending on the extrasynaptic GABAA receptor isoforms targeted. For neurons, this resulted in differential
modulation of GABA tonic currents, depending on the cell type studied, their respective GABAA receptor subunit compositions, and
critically, on the ambient GABA levels. Unexpectedly, 4-PIOL revealed a significant population of relatively low-affinity 2 subunit-
containing GABAA receptors in the thalamus, which can contribute to tonic inhibition under specific conditions when GABA levels are
raised. Together, these data indicate that partial agonists, such as 4-PIOL,may be useful formodulating GABAA receptor-mediated tonic
currents, but the direction and extent of this modulation is strongly dependent on relative expression levels of different extrasynaptic
GABAA receptor subtypes, and on the ambient GABA levels.
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Introduction
GABAA receptors are the major inhibitory ligand-gated ion chan-
nels in themammalianCNS. To date, eight classes of GABAA recep-
tor subunits have been identified, one-half ofwhich exhibitmultiple
isoforms: (1–6), (1–3), (1–3), , , , , 	(1–3) (Smart, 2015).
Theymediate their physiological effects via two temporally and spa-
tially distinct forms of signaling, denoted as phasic and tonic inhibi-
tion.Phasic inhibition involves the activationof synaptically located,
usually(1–3)2GABAA receptors, by transientlyhigh concentra-
tions (mM) of GABA (Maconochie et al., 1994; Jones and West-
brook, 1995), whereas tonic inhibition relies on the continuous
activation of extrasynaptic (typically 4/6) GABAA receptors, by
ambientGABAconcentrations (nM–
M;FarrantandNusser, 2005),
though other isoforms will also contribute, such as 5, 1, and
1 assemblies (Caraiscos et al., 2004;MortensenandSmart, 2006;
Glykys et al., 2007, 2008).
Imbalanced tonic inhibition is associated with a wide range of
neurological disorders (Belelli et al., 2009; Brickley and Mody,
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Significance Statement
A background level of inhibition (tonic) is important in the brain for controlling neuronal excitability. Increased levels of tonic
inhibition are associated with some neurological disorders but there are no specific ligands capable of selectively reducing tonic
inhibition. Here we explore the use of a GABA partial agonist as a selective chemical tool in three different brain regions. We
discover that the activity of a partial agonist is heavily dependent upon the GABAA receptor subunit composition underpinning
tonic inhibition, and on the ambient levels of GABA in the brain.
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2012). In particular, enhanced tonic currents, arising from ele-
vated ambient GABA levels in the brain, are implicated in the
pathology of absence seizures, cognitive disorders, and motor
deficits following stroke (Cope et al., 2009; Clarkson et al., 2010;
Jo et al., 2014;Wu et al., 2014). Consequently, emerging evidence
indicates that antagonists and/or inverse agonists that selectively
inhibit extrasynaptic 5- and/or -containing GABAA receptors
may prove therapeutically useful for such conditions (Navarro et
al., 2002; Atack et al., 2006; Ballard et al., 2009; Cope et al., 2009;
Atack, 2010; Clarkson et al., 2010; Braudeau et al., 2011;
Martínez-Cue´ et al., 2013). Unfortunately, although several com-
pounds selectively enhance - or 5-mediated tonic currents,
such as THIP, DS2, AA29504, and Thio-4-PIOL (Sto´rustovu and
Ebert, 2006; Wafford et al., 2009; Hoestgaard-Jensen et al., 2010,
2013; Jensen et al., 2013), only one compound (DPP-4-PIOL)
appears to selectively inhibit -mediated tonic currents (Boddum
et al., 2014). Moreover, clinical trials involving 5-selective in-
verse agonists (5IA and L-655,708) have foundered due to ad-
verse effects (Rudolph and Mo¨hler, 2014).
As an alternative to GABAA receptor antagonists, we hypoth-
esized that low-efficacy partial agonists may act as “functional
antagonists”, given their ability to compete with GABA for the
orthosteric binding site, and their reduced ability to activate
GABAA receptors.Moreover, low-efficacy partial agonistsmay be
less likely to induce convulsions, or unwanted side effects
(Krogsgaard-Larsen et al., 2002). Here the subtype-selective pro-
file of the low-efficacy partial agonist, 5-(4-piperidyl)isoxazol-
3-ol (4-PIOL; Kristiansen et al., 1991; Frølund et al., 1995;
Mortensen et al., 2002, 2004) was assessed on recombinant and
neuronal GABAA receptors. The activity profile of 4-PIOL on
tonic and phasic currents varied between three selected brain
regions. This revealed a strong dependence on GABAA receptor
subunit composition, and on ambient GABA levels, and helped
uncover a population of largely silent GABAA receptors in the
thalamus that can contribute to tonic inhibition under specific
conditions. Overall, partial agonists may be useful as therapeutic
agents, but their effectiveness will critically depend on which
GABAA receptor isoforms are present and the extent of their
activation.
Materials andMethods
Transient receptor expression in HEK293 cells.Human embryonic kidney
(HEK) 293 cells were cultured inDMEM, as previously described (Wool-
torton et al., 1997). HEK cells were plated onto poly-L-lysine-coated
coverslips and transfected using a calcium phosphate protocol. Briefly,
GABAA receptor pRK5 cDNAs, with enhanced green fluorescent protein
(eGFP) cDNA, were mixed with 340 mM CaCl2, and an equal volume of
HEPES-buffered saline (50 mM HEPES, 280 mM NaCl and 2.8 mM
Na2HPO4, pH 7.2). One microgram of each cDNA was used, and a total
of 4 
g cDNA was used for each transfection. The cDNA-calcium phos-
phate suspension was applied to cells, which were incubated overnight,
and used for electrophysiology 18–48 h after transfection.
Culturing of cerebellar granule cells. Cerebellar cultures were prepared,
as described previously (Houston and Smart, 2006) using postnatal day
(P)4 Sprague-Dawley rats, prepared in accordance with the UK Animals
Scientific Procedures Act (1986). Cells were dissociated using 0.1% w/v
trypsin and mechanical trituration before plating onto glass coverslips
coated with 500 
g/ml poly-D-ornithine, in basal medium eagle (BME)
supplementedwith 10%v/v heat-inactivated fetal calf serum (FCS). After
1 h, the medium was replaced with BME containing 5% v/v heat-
inactivated horse serum (HS; Invitrogen), 20U/ml penicillinG, 20
g/ml
streptomycin, 2mM L-glutamine, 0.5% v/v glucose and a growthmixture
(5 mg/L insulin, 5 mgl/L transferrin, 5 mg/L selenium; Sigma-Aldrich).
Electrophysiological recordings were performed from cultured cerebel-
lar granule cells (CGCs), between 7–19 d in vitro (DIV).
Culturing hippocampal neurons.Hippocampal cultures were prepared
from E18 rat embryos, as previously described (Thomas et al., 2005).
Cells were dissociated, as above, before plating onto glass coverslips
coated with 100 
g/ml poly-D-lysine (Sigma-Aldrich) in minimum es-
sentialmedia (Invitrogen) supplementedwith 5%v/v FCS, 5%v/vHS, 10
U/ml penicillin-G, 10 
g/ml streptomycin, 2 mM L-glutamine, and 20
mM glucose. After 2 h, themedia was replaced with Neurobasal-A (Invit-
rogen) media supplemented with 1% v/v B-27 (Invitrogen), 50 U/ml
penicillin-G, 50 
g/ml streptomycin, 0.5% v/v Glutamax (Invitrogen),
and 35 mM glucose. Electrophysiological recordings were performed be-
tween 11 and 21 DIV.
Acute brain slice preparation. Young rats (P14) were terminally anes-
thetizedwith isoflurane. The brainwas rapidly removed and immersed in
ice-cold slicing solution composed of the following (in mM): 130
K-gluconate, 15 KCl, 0.05 EGTA, 20 HEPES, 4 Na-pyruvate, 25 glucose,
and 2 kynurenic acid, pH 7.4. Coronal (thalamus and hippocampus) or
parasagittal (cerebellum) slices (all 250
m) were made using a Leica VT
1200s vibroslicer, and transferred to a holding chamber incubated at
37°C. The solution was slowly exchanged for artificial CSF (aCSF)
containing the following (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4,
26 NaHCO3, 2 CaCl2, 1 MgCl2, 25 glucose, and 2 kynurenic acid (pH
7.4 when bubbled with 95% O2 and 5% CO2). Slices were maintained
in the holding chamber at room temperature until required for
electrophysiology.
Drug solutions. ForHEK293 cells, GABAwas applied alone, or in com-
bination with other drugs using a Y-tube application system (Mortensen
and Smart, 2007). The 10–90% solution exchange times of the applica-
tion system were within 20–30 ms as measured in open pipette tip re-
cordings. GABA and bicuculline were obtained from Sigma-Aldrich,
THIP and DS2 were purchased from Tocris Biosciences, and diazepam
was sourced from Roche. Drug solutions were either prepared from wa-
ter or DMSO concentrated stocks, or dissolved directly into the extracel-
lular medium, depending on the final concentration. Drug solutions
were corrected for pH before use.
Data acquisition. Whole-cell currents were recorded using an Axo-
patch 200B amplifier. Currents were filtered at 5 kHz, digitized at 50 kHz
via a Digidata 1332A (Molecular Devices), and recorded to disk (Dell
Pentium Dual Core-Optiplex 960). Series resistances were monitored
throughout each experiment and deviations 20% resulted in the data
being excluded from further analysis.
HEK293 cell electrophysiology. HEK293 cells were continuously per-
fused with Krebs solution containing the following (in mM): 140 NaCl,
4.7 KCl, 1.2MgCl2, 2.52 CaCl2, 11 glucose, and 5HEPES, adjusted to pH
7.4 with 1 M NaOH. Patch pipettes were fire polished to 2–4 M and
filledwith an intracellular solution containing the following (inmM): 120
KCl, 1 MgCl2, 11 EGTA, 10 HEPES, 1 CaCl2, and 2 adenosine triphos-
phate, adjusted to pH 7.2 with 1 M NaOH. HEK293 cells were voltage-
clamped between20 and60 mV, depending on peak current size.
Analysis of GABA concentration–response curves. GABA-activated cur-
rents (IGABA) were normalized to the maximal current evoked by a
saturating concentration of GABA (IMax,GABA). The normalized concen-
tration–response curves were fitted using a modified Hill equation (Eq.
1), using a least-squares method.
IGABA  IMin,GABA IMax,GABA IMin,GABA
GABAnH
GABAnH  EC50
(1)
EC50 is the concentration ofGABA, [GABA], which produced 50%of the
maximal response, and nH, is the Hill coefficient. IMin,GABA is the mini-
mum “plateau” response induced in the presence of 4-PIOL. For the
GABA concentration–response curve constructed in the absence of
4-PIOL, IMin,GABA is zero. The parameters obtained from individual
curve-fittings were collated and the data were expressed as the mean 	
SEM.
Neuronal whole-cell electrophysiology. Thalamic relay neurons of the
dorsal lateral geniculate nucleus (dLGN), CA1 pyramidal neurons in the
hippocampus, and CGCs were visualized using infrared differential in-
terference contrast optics and a Basler scA750–60fm camera. Cells were
perfused with aCSF or Krebs, supplemented with 2 mM kynurenic acid,
or a mixture of 20 
M D-AP5 (Tocris Bioscience) and 10 
M CNQX
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(Abcam) to block glutamatergic currents. Recordings were made using
patch pipettes (2–4 M) filled with a solution containing the following
(in mM): 140 CsCl, 2 NaCl, 10 HEPES, 5 EGTA, 2 MgCl2, 0.5 CaCl2, 2
Na-ATP, and 2 QX-314 bromide. pH was adjusted using 1 M CsOH. In a
subset of recordings, thalamic slices were preincubated for 30 min, in
aCSF containing the GABA transporter (GAT) inhibitors, NNC-711 (10

M; Abcam) and SNAP-5114 (20 
M; Tocris Bioscience). Both com-
pounds were also present throughout the recordings. A saturating con-
centration of bicuculline (20 
M; Ueno et al., 1997) was bath-applied at
the end of all electrophysiological recordings, to confirm that all synaptic
events were GABAergic, and to reveal GABA-mediated tonic currents.
All recordings were performed at room temperature.
For tonic currents, the average holding current for a 30 s epoch in each
drug condition was measured using WinEDR software (v3.1; John
Dempster, University of Strathclyde, Glasgow, UK). Changes in holding
current were calculated by subtracting the average holding current after
drug application, from the average holding current before drug applica-
tion. In addition, the root mean square (rms) baseline noise was mea-
sured over a 30 s epoch, sampled every 100 ms. Because sIPSCs increase
rms baseline noise, Microsoft Excel was used to calculate a threshold for
eliminating contaminated 100 ms epochs. A running threshold (rou-
tinely the median) was calculated at 5 s time intervals, over a 30 s record-
ing period, and any rms value greater than the calculated threshold, was
automatically excluded from further analysis. Effective thresholding was
validated by manually analyzing a small section of each recording
(
10 s), and manually eliminating 100 ms epochs contaminated by syn-
aptic currents.
Synaptic current analysis. The sIPSC frequency was determined using
MiniAnalysis software (Synaptosoft). During 4-PIOL application, a sig-
nificant increase in rms current noise was observed that might mask
smaller sIPSCs, thereby introducing a bias toward larger events, com-
pared with control. To limit the bias, only the largest hundred amplitude
events from each condition were compared. The average decay kinetics
for sIPSCs for each cell was determined by fitting uncontaminated events
(50 events for each condition) with either a mono- or bi-exponential
decay function. To combine data obtained formono- or bi-exponentially
fitted events, decay times were transformed to a weighted decay time, w,
according to the following:
w  (A1  1 A1  2)/(A1 A2) (2)
where 1 and 2 represent decay time constants, and A1 and A2 are the
relative amplitude contributions of 1 and 2. For mono-exponential
decaying events, A2 and 2 are zero. The mean sIPSC frequency, ampli-
tude, 10–90% rise time, and w were calculated for each cell.
Results
Functional properties of synaptic-type GABAA receptors
activated by a partial agonist
To evaluate the functional profile of 4-PIOL at synaptic-type
GABAA receptors, peak whole-cell GABA currents were recorded
from 132-expressing HEK293 cells, in the absence or pres-
ence of 10, 100, or 1000 
M 4-PIOL (Fig. 1A). At these concen-
trations, 4-PIOL induced a rightward shift in the GABA
concentration–response curve, with a discernible crossover with
the control GABA curve (Fig. 1B). The GABA EC50 for 132
receptors was increased from 4.5 	 1.9 
M in control, to 9.4 	
3.4, 15.4	 5.4, and 126.7	 55.6 
M in the presence of 10, 100,
and 1000 
M 4-PIOL, respectively. Pre-application of 4-PIOL to
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Figure 1. Functional properties of recombinant132 GABAA receptors activated by 4-PIOL.A, Representativewhole-cell current traces elicited by GABA in the presence of preapplied 4-PIOL
(1 mM), for132-expressing HEK293 cells. In this, and subsequent figures, the horizontal bars indicate the duration of drug applications; here representing GABA (black) and 4-PIOL (green)
applications.B, Mean peak GABA concentration–response curves constructed in the absence (F), or presence of 10
M (Œ), 100
M (f) or 1000
M () 4-PIOL (n 4–13; mean	 SEM). The
peak response to each concentration of GABAwasmeasured in relation to the holding current before 4-PIOL preapplication, and each datasetwas normalized to themaximum response achieved by
a saturating concentration of GABA, in the absence of 4-PIOL. The normalized concentration–response curves were fitted using amodified Hill equation (black and colored lines), to account for the
elevated curveminima induced by 4-PIOL. The red hatched boxes represent concentrations of GABA proposed to exist at extrasynaptic (100 nM–1
M) and synaptic sites (1mM). C, An expanded
part of the GABA concentration–response curves presented in B. Note the elevated curve minima induced by 100 and 1000
M 4-PIOL. D, Example whole-cell current traces elicited by 1mM GABA
in the absence, or presence of preapplied 10
M 4-PIOL (blue bar).
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132-expressing cells revealed a small agonist response,
particularly with 100 or 1000 
M 4-PIOL (Fig. 1A). This ago-
nist activity appeared on the concentration–response curves
by an elevated minimum response (Fig. 1B,C) with 100 and
1000 
M 4-PIOL inducing agonist currents that were 5.5 	
3.2% and 6.8 	 1.3% of the maximum GABA response (Fig.
1C). Crucially for this synaptic GABAA receptor subtype, nei-
ther 10 nor 100 
M 4-PIOL inhibited the maximum responses
to higher, synaptic concentrations of GABA (percentage con-
trol: 98.8	 1.2% and 98.7	 1.3% for 10 and 100 
M 4-PIOL
at 1 mM GABA; Fig. 1D), indicating that at these concentra-
tions of 4-PIOL, the partial agonist is potentially capable of
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Figure2. Functional effects of 4-PIOLon steady-stateGABAcurrents. Representativewhole-cell currents inducedby longapplicationsof 0.1 and1
MGABA to42 (A),62 (B),532
(C), and132 (D) receptors. 4-PIOL (10
M) was briefly coapplied once a steady-state GABA current was achieved. E, Quantitative analysis of data depicted in A–D. Data points for132
(),532 (f),62 (Œ), and42 (F) receptors are mean	 SEM (n 4–5 cells). For each concentration (0.1, 0.3, and 1
M) of preapplied GABA, the change in holding current
produced by 4-PIOL is expressed as a percentage of the steady-state current to GABA alone. Negative values represent an inhibition of the steady-state GABA current.
Table 1. sIPSC parameters for cultured cerebellar granule and hippocampal
neurons
CGCs Hippocampal neurons
Control 4-PIOL Control 4-PIOL
Frequency, Hz 7.2	 1.0 4.5	 1.3 6.9	 1.7 4.0	 1.6*
Amplitude, pA 409	 113 374	 123 361	 101 243	 63**
10–90% rise time, ms 1.1	 0.1 1.2	 0.1 2.0	 0.3 2.1	 0.3
Decay tau, ms 17.7	 1.6 19.8	 1.7 31.4	 3.0 31.7	 3.7
All data are presented as mean	 SEM (n 5–6). Control and 4-PIOL data were compared using a paired t test.
*p 0.05, **p 0.01.
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inhibiting responses to predicted extrasynaptic concentra-
tions of GABA, without depressing synaptic GABA currents.
Functional properties of extrasynaptic-type GABAA receptors
activated by a partial agonist
Given the minimal efficacy displayed by 10 
M 4-PIOL at 12
receptors, and its potential to not inhibit synaptic currents in
neurons, we further characterized the effects of 10
M 4-PIOL on
extrasynaptic-type GABAA receptors expressed in HEK293 cells.
Low ambient concentrations of GABA (0.1, 0.3, and 1 
M), were
preapplied to 42-, 62-, and 532-expressing HEK293
cells, until a steady-state response was achieved, and subse-
quently, GABA was coapplied with 10 
M 4-PIOL (Fig. 2A–C).
For 42 receptors, coapplication of 4-PIOL significantly
inhibited the steady-state GABA current for 0.1, 0.3, and 1 
M
GABA by 70.6	 2.7%, 56.1	 4.5%, and
31.5	 1.3%, respectively (Fig. 2A,E; p
0.03, 0.04, and 0.02, respectively). By con-
trast, only a modest inhibition of steady-
state currents was produced by 4-PIOL at
recombinant 62 receptors for the
lowest concentrations of GABA (by
26.5	 3.9% and 20.9	 3.0 for 0.1 and 0.3

M; p 0.007 and 0.006; Fig. 2B), but not
for 1 
M GABA (percentage inhibition:
9.6 	 4.0%; p  0.31). For recombinant
532 receptors, the functional profile
of 10
M4-PIOL varied, depending on the
ambient GABA concentration (Fig. 2C).
4-PIOL enhanced the steady-state current
elicited by 0.1
MGABA (by 23.0	 1.5%;
p  0.004), was ineffective at 0.3 
M
GABA (a 1.5 	 0.8% enhancement; p 
0.2), and produced a small inhibition
(6.8 	 0.9%; p  0.02) of steady-state
GABA currents induced by 1 
M GABA.
In addition, the effects of 4-PIOL were
assessed on 132 receptors at low ex-
trasynaptic GABA concentrations (Fig.
2D), because their presence at extrasynap-
tic sites has also been suggested in several
neuronal cell types (Nusser et al., 1998;
Mangan et al., 2005; Thomas et al., 2005;
Kasugai et al., 2010). 4-PIOL significantly
enhanced the response to 0.1 
M GABA
by 76.9	 21.5% (Fig. 2E; p 0.02). How-
ever, when coapplied with 1 
M GABA,
4-PIOL produced a small inhibition of the
steady-state GABA current (12.9	 3.3%;
Fig. 2E; p 0.05).
There is some evidence for the expres-
sion of native  receptors lacking either a  or  subunit at
extrasynaptic sites in cerebellar and hippocampal neurons
(Brickley et al., 1999;Mortensen and Smart, 2006). Therefore, we
also assessed the effects of 4-PIOL on 13 receptors. Similar to
the -containing receptors, 10 
M 4-PIOL showed no agonist
behavior at these receptors, but instead inhibited steady-state
currents activated by low GABA concentrations (by 69 	 7%,
75	 2%, and 75	 2% at 0.1, 0.3, and 1
MGABA, respectively).
Overall, these data indicate that 10 
M 4-PIOL may potently
inhibit 42-mediated tonic currents, without affecting
132-mediated phasic currents. Moreover, 10 
M 4-PIOL is
expected to produce only a modest effect on 62-mediated
tonic currents (eg, in the cerebellum), whereas any inhibition of
extrasynaptic 2-containing receptors, althoughminimal, will be
strongly dependent on the ambient GABA concentration in neu-
ronal preparations. Although our earlier studies suggested that
 receptors represent only a modest component of the extra-
synaptic GABAA receptor population in hippocampal pyramidal
cells (
10%; Mortensen and Smart, 2006), their contribution to
the tonic current will be inhibited by 10 
M 4-PIOL.
Examining GABAA receptor-mediated tonic and phasic
inhibition with a partial agonist
As our observations indicated that 4-PIOL may have differential
effects on synaptic and extrasynaptic GABAA receptors, we chose
to explore the functional profile of 4-PIOL on tonic and phasic
GABA currents in neurons. Initially, whole-cell recordings were
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Figure 3. Characterizing GABAA receptor-mediated tonic and 4-PIOL-activated currents in cultured neurons. Representative
currents fromculturedCGCs (A) andhippocampalneurons (HNs;C) in thepresenceof CNQX (10
M)andD-APV (20
M). Bicuculline
(BIC; 20
M)wasapplied for theduration indicated.All recordingswereperformedat roomtemperatureand theholdingpotentials
were60mV.B,D, Representative recordings from a CGC (B) and a hippocampal neuron (D), showing the effect of 10
M 4-PIOL
application on sIPSCs and holding current. E, F, Bar graphs for GABAA receptor-mediated tonic currents (E) and 4-PIOL-activated
currents (F ) from CGCs (n 5) and hippocampal neurons (n 6; bars are mean	 SEM). Tonic currents were calculated by
subtracting the average holding current after BIC application from the average holding current in control Krebs.
Table 2. 4-PIOL and tonic currents for cultured cerebellar granule and hippocampal
neurons
CGCs Hippocampal neurons
4-PIOL current, pA 9.8	 4.0 72.0	 14.2**
(pA/pF) (0.8	 0.3) (0.8	 0.2)
Tonic current, pA 22.8	 8.5* 42.8	 6.3**
(pA/pF) (1.8	 0.9) (0.3	 0.1)
Data shown are the mean currents (	SEM, n 5–6) evoked by 10 
M 4-PIOL and 20 
M bicuculline (tonic
current). According to normal convention, inward and outward currents have negative and positive polarities,
respectively. Currents normalized to cell capacitance (pA/pF) are shown in parentheses below the absolute values.
Statistical significance was assessed using a paired t test. *p 0.05, **p 0.01.
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performed on cultured hippocampal and
cerebellar granule (CGC) neurons. Under
control recording conditions, a high fre-
quency of sIPSCs were recorded from
CGCs (7.2 	 1.0 Hz) and hippocampal
neurons (6.9 	 1.7 Hz; Table 1), which
displayed mean sIPSC amplitudes of
409 	 113 and 361 	 101 pA (Table 1),
respectively. A saturating concentration
of bicuculline (20 
M) was applied at the
end of the recordings to confirm that all
synaptic events were GABAergic, and to
measure the amplitudes of GABAA
receptor-mediated tonic currents. As ex-
pected, for both cell types, bicuculline
abolished the sIPSCs and induced out-
ward shifts in the membrane holding cur-
rent, indicative of GABA tonic currents
(Fig. 3A,C). For CGCs and hippocampal
neurons, the basal tonic current ampli-
tudes were as follows: 22.8 	 8.5 and
42.8	 6.3 pA (Fig. 3E; Table 2).
To assess the effects of 4-PIOL on the
tonic and phasic currents, 10 
M 4-PIOL
was applied to cells following a period of
control recording (Fig. 3B,D). For CGCs,
4-PIOL showed a very small tendency to
enhance the tonic current by 9.8	 4.0 pA
(Fig. 3B,F), however, this was not statis-
tically significant (p 0.058). 4-PIOL ex-
erted no significant effect on sIPSC
amplitude (percentage control: 93.2 	
14.9; p 0.66), rise time (percentage con-
trol: 107 	 4.1; p  0.24), or frequency
(percentage control: 64.0 	 14.2; p 
0.057) in CGCs (Table 1).
By comparison, in hippocampal neu-
rons, 10 
M 4-PIOL significantly en-
hanced the GABA-mediated tonic current
by 72.0 	 14.2 pA (p  0.0025; Fig.
3D,F). Given that 10 
M 4-PIOL did not
inhibit the synaptic-type responses of re-
combinant 12 receptors, it was unex-
pected that 4-PIOL also significantly
inhibited both the frequency (percentage
control: 49.8	 9.5%; p 0.002) and the
amplitude of sIPSCs (percentage control:
58.6	 16.8%; p 0.047, Wilcoxon matched pairs test), but did
not affect the rise time (percentage control: 110	 12.1; p 0.50)
or w (percentage control: 100 	 3.4; p  0.75) of sIPSCs
(Table 1).
For both types of cultured neurons, we used the -subunit
selective agonist, THIP, to assess the presence of -containing
GABAA receptors. Application of 1 
M THIP evoked significant
inward currents, confirming the surface expression of extrasyn-
aptic -GABAA receptors in the cultured cell preparations
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Figure 4. Characterizing GABAA receptor-mediated tonic and 4-PIOL-activated currents recorded fromneurons in acute slices.
Representative whole-cell currents for CGCs (A, B), CA1 hippocampal neurons (HNs; C, D), or dLGN relay neurons (E, F ), showing
the effects of 20
M bicuculline (BIC) and 10
M 4-PIOL application (indicated by black and gray bars, respectively) on sIPSCs and
holding currents. Bicuculline blocks sIPSCs and reveals tonic GABAA currents in all three cell types. 4-PIOL has little effect on
holding current in CGCs, induces outward or inward currents in hippocampal neurons, and causes large inward currents in dLGN
relay neurons.G,H, Bar charts showing the tonic currents (G) and 4-PIOL-evoked currents (H ), for CGCs (n9), CA1hippocampal
neurons (n 7–8), and dLGN relay neurons (n 42). All recordings were performed at room temperature, in the presence of 2
mM kynurenic acid. The holding potential was60 mV.
Table 3. sIPSC parameters for cerebellar granule, CA1 hippocampal, and dLGN relay neurons in acute slices
CA1 pyramidal neurons
CGCs Inward 4-PIOL Outward 4-PIOL dLGN relay neurons
Control 4-PIOL Control 4-PIOL Control 4-PIOL Control 4-PIOL
Frequency, Hz 1.5	 0.3 1.1	 0.2* 2.0	 0.5 1.1	 0.3* 0.6	 0.1 0.6	 0.1 11.5	 1.6 1.5	 0.3**
Amplitude, pA 185	 36 120	 14* 49	 13 31	 4 20	 2 17	 2* 56.4	 4.3 40.2	 2.7*
10–90% rise time, ms 0.9	 0.1 0.9	 0.1 1.2	 0.2 1.0	 0.1 1.2	 0.2 1.0	 0.2
Decay tau, ms 18.4	 3.1 18.7	 2.5 23.9	 2.2 22.7	 3.0 21.5	 1.6 19.7	 2.1
All data are presented as mean	 SEM (n 4–8). Values for CA1 pyramidal neurons are divided according to direction of 4-PIOL response. Control and 4-PIOL data were compared using a paired t test. *p 0.05, **p 0.01.
612 • J. Neurosci., January 13, 2016 • 36(2):607–621 Patel et al. • Partial Agonist and Tonic Inhibition
(CGCs: 22.4	 8.7 pA, n 9; hippocampal neurons: 40.8	 5.8
pA, n 16).
To characterize the effects of 4-PIOL under more physiologi-
cal conditions, we recorded fromCGCs, hippocampal CA1 pyra-
midal neurons and thalamic relay neurons of the dorsal lateral
geniculate nucleus in acute brain slices. These three cell types
were selected because their GABAA receptor-mediated tonic cur-
rents are thought to be mediated largely by 6, 5, and
4 GABAA receptors, respectively (Jones et al., 1997; Brickley
et al., 2001; Caraiscos et al., 2004; Cope et
al., 2005; Glykys et al., 2008).
Application of bicuculline (20 
M)
blocked the sIPSCs (parameters shown in
Table 3) and revealed GABAA receptor-
mediated tonic currents in all three cell
types (Fig. 4A,C,E,G). For CGCs, hip-
pocampal neurons and dLGN relay neu-
rons, the basal tonic current amplitudes
were as follows: 9.8	 4.3, 19.2	 2.7, and
23.8	 2.1 pA (Fig. 4G; Table 4).
As with the cultured cells, 10 
M
4-PIOL had little impact on the tonic cur-
rent recorded fromCGCs in slices (change
in holding current 0.05 	 1.44 pA; Fig.
4B,H). However, in contrast to the cul-
tured cells, 4-PIOL significantly inhibited
both the frequency (percentage control:
76.7 	 6.1%; p  0.006; Table 3) and the
amplitude of sIPSCs (percentage control:
71.2 	 4.2%; p  0.0002, Wilcoxon
matched-pairs test), but did not affect the
rise time (percentage control: 101.6	 3.3;
p 0.63) or decay w (percentage control:
105.6	 5.2; p 0.32).
By comparison, in hippocampal CA1
pyramidal neurons, 10
M 4-PIOL evoked
a dichotomous response, with cells either
displaying an inward current (24.7	 5.7
pA, n  7, p  0.002) or a small, but sig-
nificant outward current (7.8 	 1.6 pA,
n  8, p  0.001; Fig. 4D,H). Interest-
ingly, when we divided cells according to
their 4-PIOL response, we found that neu-
rons showing an outward current had a
larger basal tonic current than those cells
producing an inward 4-PIOL current
(outward 24.2	 4.4 pA, inward 13.5	 1.1
pA, p 0.04, unpaired t test; Fig. 4G). Di-
viding cells in this way, also revealed a dif-
ference in the modulation of synaptic
inhibition by 4-PIOL. For the inward cur-
rent cohort, 4-PIOL caused a significant
reduction in IPSC frequency (percentage
control: 54.2	 8.1%, p 0.04), but had no significant effect on
synaptic GABA release for the outward current cohort (percent-
age control: 150.0	 43.0%, p 0.91; Table 3).
Applying 4-PIOL to dLGN slices significantly enhanced tonic
currents by 57.4	 3.3 pA (Fig. 4F,H), and notably reduced both
the frequency (percentage control: 13.3	 2.2%; p 0.001) and
amplitude of sIPSCs (percentage control: 71.8	 2.7%; p 0.01;
Table 3), relative to synaptic events measured in control aCSF.
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Figure5. THIPandbicucullinemodulationof 4-PIOL currents.A, Representativemembrane current recorded fromadLGN relay
neuron (left) in response to applied 4-PIOL (10
M), in the absence or presence of BIC (20
M). The bar chart (right) depicts the
mean	 SEM (n 4) for the 4-PIOL current in BIC (white) expressed as a percentage of the control 4-PIOL response (gray)
recorded from the same dLGN relay neurons.B, Membrane currents recorded from a42-expressing HEK293 cell in response
to THIP (1
M, blue bar) and 4-PIOL (10
M, gray bar). Bar chart shows the steady-state THIP current in the absence or presence
of 4-PIOL (n 4). Significance was assessed using a paired t test,*p 0.05. C, Membrane currents recorded from a dLGN relay
neuron in response to THIP (1
M) and 4-PIOL (10
M). Bar chart shows the magnitude of the 4-PIOL current in the absence or
presence of THIP (n 5).
Table 4. 4-PIOL and tonic currents for cerebellar granule, CA1 hippocampal, and dLGN relay neurons in acute slices
CA1 pyramidal neurons
CGCs Inward 4-PIOL Outward 4-PIOL dLGN relay neurons
4-PIOL current, pA 0.05	 1.44 24.7	 5.7** 7.8	 1.6** 57.4	 3.3**
(pA/pF) (0.18	 0.38) (0.20	 0.06) (0.05	 0.01) (0.34	 0.03)
Tonic current, pA 9.8	 4.3* 13.5	 1.1*** 24.2	 4.4*** 23.8	 2.1**
(pA/pF) (2.57	 1.76) (0.10	 0.01) (0.13	 0.03) (0.13	 0.01)
Data shown are the mean currents (	SEM, n 7–42) evoked by 10
M 4-PIOL and 20
M bicuculline (tonic current). According to normal convention, inward and outward currents have negative and positive polarities, respectively.
Currents normalized to cell capacitance (pA/pF) are shown inparentheses below the absolute values. Values for CA1pyramidal neurons are divided according todirection of 4-PIOL response. Statistical significancewas assessedusing apaired
t test. *p 0.05, **p 0.01, ***p 0.001.
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Because of the low frequency and ampli-
tude of sIPSCs in the presence of 4-PIOL,
and the increase in rms baseline noise in-
duced by 4-PIOL (13.2	 1.6 pA), no de-
tailed analysis of sIPSC decay or rise times
was performed for dLGN relay neurons.
To further investigate the modulation
of synaptic inhibition by 4-PIOL, we re-
peated these experiments in the presence
of TTX (500 nM) to block action
potential-dependent GABA release. Un-
der these conditions, dLGN relay neurons
displayed a smaller basal tonic current
compared with aCSF control recordings
(TTX: 13.5	 1.7 pA; aCSF: 23.8	 2.1 pA;
p  0.0005, unpaired t test) consistent
with a reduced ambient GABA concentra-
tion (Bright et al., 2007). Application of 10

M 4-PIOL induced a similar increase in
tonic current as in aCSF (TTX: 43.2	 7.0
pA; aCSF: 57.4 	 3.3 pA; p  0.09, un-
paired t test) but had less effect on IPSC
frequency (percentage control: 76.5 	
9.3%; p  0.03) and amplitude (percent-
age control: 89.7	 4.7%; p 0.04, n 9).
Probing the identity of GABAA
receptors in dLGN relay neurons
According to our recombinant expression
studies, 10 
M 4-PIOL showed no dis-
cernible agonist activity at 4 recep-
tors, and was predicted to reduce
GABA-mediated tonic currents at these
receptors, assuming that the ambient
GABA concentration in slices is 
 0.1–1

M GABA (Fig. 2E). Because tonic cur-
rents in dLGN relay neurons are thought
to be mediated by 4 receptors (Cope
et al., 2005; Bright et al., 2007; Nani et al.,
2013; Ye et al., 2013), the finding that
4-PIOL showed agonist behavior, by en-
hancing tonic currents in dLGN relay
neurons, was unexpected. To verify the
GABAergic origin of this current, we used
bicuculline. Current responses to 10 
M
4-PIOL were abolished in the presence of
coapplied bicuculline (percentage control 4-PIOL response:
2.2 	 0.5; Fig. 5A), indicating that 4-PIOL was exclusively acti-
vating GABAA receptors to induce an inward current.
To investigate whether the 4-PIOL current in dLGN relay
neurons was mediated by -containing GABAA receptors, we as-
sessed the ability of 4-PIOL to compete with a  subunit-selective
concentration of the GABAA receptor agonist, THIP (1 
M;
Brown et al., 2002; Sto´rustovu and Ebert, 2006; Mortensen et al.,
2010). If THIP and 4-PIOL compete for the same orthosteric
binding site, we might expect the THIP-induced currents to be
reduced by 4-PIOL, given the lower efficacy and potency dis-
played by 4-PIOL. THIP (1 
M) was preapplied to recombinant
42 receptors expressed in HEK293 cells, until a steady-state
current was achieved, and subsequently 10
M 4-PIOL was coap-
plied with THIP (Fig. 5B). Indeed, under these conditions,
4-PIOL reduced the steady-state THIP current, from 202.3 	
70.7 to 68.2	 30.1 pA (Fig. 5B; p 0.02), suggesting that 4-PIOL
is competing with THIP for the orthosteric binding site.
If 4-PIOL is acting on -containing receptors in dLGN relay
neurons, we might also expect 4-PIOL (10 
M) to reduce the
steady-state THIP (1 
M) current in dLGN relay neurons. As
expected, THIP significantly enhanced the dLGN tonic current
by 96.6 	 12.6 pA, confirming the functional expression of 
subunit-containing receptors.However, coapplication of 4-PIOL
with THIP generated a further inward current (58.6 	 6.6 pA;
Fig. 5C), with a mean magnitude that was similar to the control
4-PIOL current (57.4 	 3.3 pA; p  0.67). These data indicate
that THIP and 4-PIOL may not be competing for the same 
subunit-containing receptors in dLGN relay neurons.
To further probe whether the 4-PIOL current in dLGN relay
neuronswasmediated by -containing receptors, we investigated
whether the 4-PIOL current could be modulated by the 
subunit-selective positive allosteric modulator, DS2 (Wafford et
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al., 2009; Jensen et al., 2013). Whole-cell 10 
M 4-PIOL currents
were recorded in the absence or presence of a -selective concen-
tration ofDS2 (10
M; Fig. 6A). DS2 alone significantly enhanced
dLGN tonic currents (Fig. 6A), giving rise to a bicuculline-
sensitive current thatwas significantly greater (136	 23 pA) than
that measured in control aCSF (23.8 	 2.1 pA; p  0.002). In-
triguingly, DS2 also potentiated the 4-PIOL current (percentage
control 4-PIOL response: 236.3 	 28.9; Fig. 6A; p  0.0001),
indicating that the 4-PIOL current in dLGN relay neurons might
be mediated by -containing receptors.
Previously, the modulatory actions of DS2 have only been
characterized on GABA-mediated currents (Wafford et al., 2009;
Jensen et al., 2013), and not on responses evoked by otherGABAA
receptor agonists. To investigate, we monitored the effect of 10

M DS2 on whole-cell 4-PIOL currents using recombinant
42 (Fig. 6B) and 132 (Fig. 6C) receptors, expressed sep-
arately in HEK293 cells. Under control conditions, 4-PIOL (10

M) elicited no discernible agonist response at 42 receptors
(Fig. 6B), but induced a small inward current at 132 recep-
tors (Fig. 6C). However, coapplying DS2 with 4-PIOL, unveiled
an agonist current at 42 receptors, which was 8.9	 3.8% of
the response to 1mMGABA in the same cell (Fig. 6B). Unexpect-
edly, DS2 also potentiated the 4-PIOL
current mediated at 132 receptors
(percentage control 4-PIOL current:
153.8	 24.7%; Fig. 6C; p 0.017), albeit
to a lesser extent than that observed at
42 receptors. These findings compli-
cate the interpretation of DS2-mediated
potentiation of the 4-PIOL current in
dLGN relay neurons, because DS2 may
be modulating a population of 2-
containing GABAA receptors, or generat-
ing a -mediated component to the
4-PIOL current, whichmaynot be present
under control conditions.
Because 10 
M 4-PIOL activated 2-
containing receptors, but not -containing
receptors in our recombinant expression
studies, we explored the possibility that
4-PIOL was activating a population of 2-
containing receptors in dLGN relay neu-
rons. The presence of 2-containing
receptors was examined using the benzodi-
azepine agonist, diazepam. Preapplication
of 500 nM diazepam significantly increased
the dLGN tonic current, giving rise to a
bicuculline-sensitive tonic current (52.0 	
5.6 pA) that was significantly greater than
that measured in control aCSF (23.8	 2.1
pA; Fig. 7A; p 0.003). Diazepam also in-
creased the amplitude of the IPSCs suggest-
ing that GABA release at these thalamic
inhibitory synapses was not saturating. Co-
application of 4-PIOL with diazepam re-
vealed a significantly larger inward current
than the control 4-PIOL current (percent-
age control 4-PIOL response: 160.3 	
14.3%; Fig. 7A; p 0.003), indicating that a
substantial component of the 4-PIOL cur-
rent is most likely mediated by 2-
containing receptors in dLGN relay
neurons.
To confirm that diazepam would only potentiate the agonist
responses of 2 subunit-containing GABAA receptors (Pritchett
et al., 1989), whole-cell currents were recorded from recombi-
nant132 (Fig. 7B) or42 Fig. 7C) receptors in response to
brief applications of 4-PIOL (10 
M) in the absence or presence
of preapplied diazepam (500 nM). At 132 receptors, diaze-
pam significantly potentiated 4-PIOL responses (percentage con-
trol response: 246.6	 50.1; Fig. 7B; p 0.03); and, as expected,
4-PIOL (10
M) elicited no discernible agonist response at42
receptors, either in the absence or presence of diazepam (Fig. 7C).
A saturating concentration of GABA (1 mM) was applied to each
42-expressing cell, to confirm the functional expression of
42 receptors (Fig. 7C).
Together, these data indicate that although  subunit-
containing receptors are expressed in dLGN relay neurons, as
confirmed by THIP and DS2 modulation of basal tonic currents,
the 4-PIOL current appears to be largely mediated by 2-
containing receptors, with little, or no, contribution from 
subunit-containing receptors.
Given these findings, we explored which GABAA receptor iso-
forms underpin tonic currents in dLGN relay neurons. Since
tonic currents in these cells are thought to be mediated by 
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subunit-containing receptors (Cope et al., 2005; Bright et al.,
2007; Nani et al., 2013; Ye et al., 2013), we investigated whether
there was a correlation between currents induced by a -selective
concentration of THIP (1 
M) and by bicuculline, for individual
dLGN relay neurons. 4-PIOL and bicuculline were individually
applied (Fig. 8A), and to account for variation in cell size, the
holding currents were normalized towhole-cell capacitance (pF).
A scatter plot comparing current densities revealed a positive
correlation (Fig. 8B; r 0.61; p 0.02). Thus, cells with a larger
THIP-induced current also displayed larger GABAA receptor-
mediated tonic currents. These data indicate that a higher expres-
sion of  subunit-containing receptors may underlie the larger
tonic currents, although other factors, such as the ambient GABA
concentration, will also be important.
If, as our previous data indicates, THIP and 4-PIOL are
acting at potentially different GABAA receptors (Fig. 5), no
positive correlation would be expected between the THIP and
4-PIOL responses in dLGN relay neurons. Indeed, a scatter-
plot of THIP and 4-PIOL currents revealed no significant
correlation (Pearson’s correlation coefficient, r  0.31; p 
0.28), supporting the notion that 4-PIOL was activating a
distinct receptor population from the -containing receptors
activated by THIP (Fig. 8C).
Because 4-PIOL and THIP are likely to be acting on different
GABAA receptors in dLGN relay neurons, it was intriguing to
explore whether the 2-containing receptors that mediate the
4-PIOL current, also contribute to dLGN tonic currents. A scat-
terplot comparing 4-PIOL and bicuculline currents recorded
from individual dLGN relay neurons showed poor correlation
(Fig. 8D; r  0.32; p  0.17), indicating that the receptors that
mediate the 4-PIOL current, are unlikely to contribute substan-
tially to basal GABAA receptor-mediated tonic currents in dLGN
relay neurons.
Modulation of tonic currents depends on ambient
GABA levels
For recombinant 132 receptors, 4-PIOL enhanced the
steady-state GABA current when the GABA concentration was
low (
0.1
MGABA), but produced a small inhibition when the
ambient GABA level was raised to 1 
M (Fig. 2D). In dLGN relay
neurons, the robust 4-PIOL enhancement of baseline tonic cur-
rents (mainly via 2 subunit-containing receptors) indicates that
the ambient GABA levels in this slice may be low (1 
M).
To determine whether 4-PIOL could switch from acting as an
agonist (at low ambient GABA levels), to acting as an antagonist
(at higher ambient GABA levels) in the native environment of
dLGN relay neurons, GABA levels were raised in slices by inhib-
iting GABA uptake. Because GABA uptake in the thalamus is
mediated by the GABA transporters, GAT1 and GAT3 (De Biasi
et al., 1998), slices were preincubated (for 30 min) and subse-
quently recorded in aCSF supplemented with the GAT1 inhibi-
tor, 10 
M NNC-711 (Borden et al., 1994) and the GAT2/3
inhibitor, 20 
M SNAP-5114 (Borden, 1996). Following a period
of control recording (in the presence of the GAT inhibitors), 10

M 4-PIOLwas applied to dLGN relay neurons and subsequently
washed out (Fig. 9A), before application of bicuculline to mea-
sure the GABA-mediated tonic current. As expected, the tonic
current was significantly larger in the presence of the GAT block-
ers compared with control aCSF (132	 19.5 and 23.8	 2.1 pA,
respectively; Fig. 9B), even when these currents were normalized
to cell capacitance (0.7 	 0.1 pA/pF and 0.1 	 0.01 pA/pF, re-
spectively; p  0.0001). These data are consistent with elevated
ambient GABA levels, in GAT-blocked slices, increasing the acti-
vation of extrasynaptic GABAA receptors.
Coapplication of 10 
M 4-PIOL with GAT inhibitors enhanced
the tonic current by 53.0 	 10.1 pA (Fig. 9A,C). This 4-PIOL-
inducedcurrentwas similar to thatobserved incontrol aCSF(57.4	
3.3 pA; Fig. 9C; p 0.47), and indicates that under control condi-
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Figure 8. Correlating THIP, BIC, and 4-PIOL currents in dLGN neurons. A, Whole-cell currents recorded from a dLGN relay neuron in response to THIP (1
M), 4-PIOL (10
M), and BIC (20
M).
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tions, 4-PIOL was not a substrate for GAT1–3. Although the in-
creased tonic current indicated that the ambient GABA level in the
slicewas raised, itmay still be too low to alter the response profile for
4-PIOL. To further increase and normalize ambient GABA levels, 1
and 3 
M GABA were individually applied to GAT-inhibited slices,
followed by coapplication with 10 
M 4-PIOL (Fig. 9A,C). Both 1
and 3
MGABA enhanced the baseline tonic current by 139	 21.8
and 301	 35.2 pA, respectively (Fig. 9C). Coapplication of 10 
M
4-PIOL with 1 
M GABA also elicited an inward current (Fig. 9A),
although the resultant 4-PIOL currentwas significantly smaller than
that observed in control aCSF (29.6	 11.5 pA; Fig. 9C). By contrast,
coapplying 10 
M 4-PIOL with 3 
M GABA produced an outward
current (27.8	 9.5.1 pA; Fig. 9A). Thus, as observed for recombi-
nant 132 receptors, 4-PIOL exhibited a dominant agonist pro-
file at low GABA concentrations (1 
M), but produced a small
inhibitionofdLGNtonic currentswhen theambientGABAconcen-
tration was increased.
To determinewhether ambientGABA levels also influence the
4-PIOL current in culturedCGCs and hippocampal neurons, low
concentrations of GABA (0.3 and 1 
M)
were preapplied until steady-state cur-
rents were achieved and subsequently,
4-PIOL was coapplied (Fig. 10A,B). Sim-
ilar to its effects on endogenous CGC
tonic currents, coapplication of 4-PIOL
produced no significant shift in the hold-
ing current, even when the preapplied
GABA concentration was raised to 1 
M
(Fig. 10A).
For hippocampal neurons, coapplica-
tion of 10 
M 4-PIOL with 0.3 
M GABA
significantly enhanced the tonic current
(Fig. 10B) by 62.8 	 9.9 pA (p  0.03,
Wilcoxon matched-pairs test), similar to
the enhancement observed under control
conditions (72.0 	 14.2 pA; p  0.90).
However, when the preapplied GABA
concentration was raised to 1 
M GABA,
10 
M 4-PIOL significantly reduced the
steady-state 1 
M GABA current (Fig.
10B), by 52.5 	 7.1 pA (p  0.0004,
paired t test). This corresponded to a
73.6	 28.1% enhancement of the steady-
state 0.3 
M GABA current, and a 12.4	
2.0% inhibition of the 1 
M GABA cur-
rent (Fig. 10C). Thus, the modulation of
tonic currents by low-efficacy partial ago-
nists, such as 4-PIOL, appears to be highly
dependent on ambient GABA levels.
Discussion
GABAA receptor-mediated tonic inhibi-
tion is an important regulator of cell and
network excitability (Mann and Mody,
2010), and its dysfunction is associated
with several pathophysiological states
(Belelli et al., 2009; Brickley and Mody,
2012). Selectively modulating the activity
of extrasynaptic GABAA receptors may
therefore be therapeutically useful for the
treatment of such disorders. Given the ab-
sence of suitable subtype-selective antag-
onists, we took a different approach by
investigating the selectivity profile of the
weak partial agonist, 4-PIOL (Mortensen et al., 2002, 2004), to
determine whether it could be used as a selective modulator of
GABA-mediated tonic currents.
Partial agonist modulation of GABA synaptic currents
Our receptor expression studies predicted that at high GABA
(synaptic) concentrations, 4-PIOL should not affect 132-
mediated currents. However, 4-PIOL variably reduced sIPSC
amplitudes and frequencies in many of our neuronal prepara-
tions. Using TTX in relay neurons revealed that 4-PIOL reduced
mIPSCs to a lesser extent than sIPSCs, which is in accord with
both presynaptic and postsynaptic effects. The reduced sIPSC
frequency is indicative of a presynaptic action, with 4-PIOL acti-
vating extrasynaptic 2-GABAA receptors, reducing interneuron
excitability and loweringGABA release (Axmacher andDraguhn,
2004). This is supported by the bidirectional 4-PIOL responses of
CA1 neurons. Cells with inward 4-PIOL currents show reduced
sIPSC frequencies, consistent with inhibition of presynaptic in-
Figure 9. 4-PIOL modulation of dLGN tonic currents depends on ambient GABA levels. A, Membrane currents recorded from
dLGN relayneurons in response to4-PIOL (10
M), coappliedwithGAT inhibitors (10
MNNC-711and20
MSNAP-5114), orGABA
(1 or 3
M) in the presence of GAT inhibitors. Slices were incubated in aCSF supplemented with GAT inhibitors for at least 30 min
before electrophysiological recordings. All recordings were performed at room temperature. B, Bar graph of BIC current in control
aCSF (black; n 30), or in the presence of GAT inhibitors (white; n 25). C, Bar graph of the mean 4-PIOL current measured in
aCSF (black;n42),GAT inhibitors (n8), orGAT inhibitorswith1
M (n11) or 3
MGABA (n4). Data arepresented
as mean	 SEM. **p 0.01, ***p 0.001, unpaired t tests.
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terneurons by 4-PIOL, whereas cells with outward currents show
no effect on IPSC frequency, reflecting unaffected interneuron
excitability. This suggests that 4-PIOL has congruent effects on
extrasynaptic 2-GABAA receptors on presynaptic interneurons
and postsynaptic pyramidal neurons, exposed to similar GABA
levels.
The residual block ofmIPSCswould suggest a small inhibition
of postsynaptic receptors. Although this was not resolved in re-
combinant 132 receptors, native GABAA receptors might
display a greater sensitivity to the actions of 4-PIOL, either due to
endogenous factors (eg, receptor phosphorylation states), or the
presence of distinct receptor subunit compositions (eg, 2 or
32 receptors).
Modulation of tonic currents depends on GABAA receptor
subunit composition
As expected for a partial agonist, 4-PIOL exhibited both agonist-
and antagonist-type behaviors at recombinant and native
GABAA receptors. However, the direction of modulation de-
pended on two critical factors: GABAA receptor composition;
and critically, the ambient GABA concentration.
GABAA receptor-mediated tonic currents in CGCs, which are
largely mediated by 6 receptors (Fritschy et al., 1992; Somo-
gyi et al., 1996; Jones et al., 1997;Nusser et al., 1998; Brickley et al.,
2001), were unaffected by 4-PIOL. This was unsurprising, given
that 4-PIOL alone produced little if any modulation of steady-
state GABA currents at recombinant 62 receptors. By com-
parison, 4-PIOL bidirectionally modulated tonic currents in
hippocampal neurons, which will express an array of GABAA
receptor isoforms, including 52, 4, and  (Mangan et
al., 2005; Mortensen and Smart, 2006; Glykys et al., 2008). This
might be expected, given that 52 receptors are important for
tonic currents in these cells (Caraiscos et al., 2004; Glykys et al.,
2008), and 4-PIOLhad a bidirectional effect onGABA currents at
recombinant 52 receptors. However, other 1–32 recep-
tor isoforms may also mediate this modulation, because tonic
currents, and the 4-PIOL current itself, were previously shown to
be positively modulated by benzodiazepine agonists in hip-
pocampal neurons (Kristiansen et al., 1995; Liang et al., 2004).
Interestingly, 4-PIOL generated both inward and outward cur-
rents in CA1 neurons under control conditions, suggesting that
the ambient GABA concentration in this slice is close to the
threshold where 4-PIOL switches from agonist to antagonist
behavior.
Extrasynaptic GABAA receptor isoforms in thalamic
relay neurons
In relay neurons, the 4-PIOL-induced enhancement of tonic cur-
rents was unexpected, because 42 receptors are thought to
underlie tonic currents in these cells (Cope et al., 2005; Bright et
al., 2007; Nani et al., 2013; Ye et al., 2013), and 4-PIOL potently
inhibited the steady-state GABA currents of recombinant 42
receptors (by 
40–80%, when the ambient GABA concentra-
tion was varied between 0.1 and 1 
M). However, several obser-
vations suggest the 4-PIOL current in relay neuronswas probably
not mediated by -containing receptors. First, despite being able
to compete with THIP for the orthosteric binding site at recom-
binant42 receptors, 4-PIOL and THIP appeared not to com-
pete for the same  subunit-containing receptors in dLGN relay
neurons. Next, the ability of 4-PIOL to bidirectionally modulate
tonic currents, strongly depended on the ambient GABA concen-
tration, recapitulating its actions at recombinant 12 recep-
tors, but not 42 receptors. Third, the 4-PIOL current in
dLGN relay neurons was potentiated by the benzodiazepine, di-
azepam, strongly implying an action at 2 subunit-containing
receptors.
To counter this, the 4-PIOL current in dLGN relay neurons
was potentiated by the  subunit-selective modulator DS2 (Waf-
ford et al., 2009; Jensen et al., 2013). It was notable that this
modulator unveiled a previously undetected 4-PIOL current at
recombinant 42 receptors and thus DS2 may act similarly at
42 receptors in dLGN, by producing a -mediated compo-
nent to the 4-PIOL current, which is absent under control con-
ditions. However, DS2 also potentiated the 4-PIOL current at
recombinant 132 receptors, bringing into question its iso-
form selectivity. DS2 modulation of 132-GABA currents has
been seen previously, and significantly, a small residual DS2-
induced current was apparent in thalamic relay neurons from 
subunit knock-out mice (Jensen et al., 2013). Thus, DS2 will
modulate 2-containing receptors, albeit to a lesser extent than
Figure 10. 4-PIOL modulation of CGC and hippocampal neurons, at varying ambient GABA concentrations. Whole-cell currents induced by 0.3 or 1
M GABA (black bars) with 4-PIOL (10
M)
coapplied once a steady-state GABA current was attained (gray bars) for CGCs (A) and hippocampal neurons (HNs;B). C, Bar graph showing themean	 SEM percentagemodulation induced by 10

M 4-PIOL (n 6). Note that positive and negative values, respectively, represent an enhancement or inhibition of the steady-state GABA current.
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-containing counterparts, and so may also be potentiating the
4-PIOL current at 2-GABAA receptors in relay neurons.
Overall, the simplest explanation for these data are that func-
tional effects of 4-PIOL on tonic currents in dLGN relay and
hippocampal neurons, are largely dominated by its actions on 2
subunit-containing receptors, though we cannot completely ex-
clude a contribution from  subunit-containing receptors. Al-
though the significant presence of extrasynaptic 2 subunit-
containing receptors on dLGN relay neurons was unexpected,
given that they are thought to accumulate at synaptic sites, im-
munohistochemical and functional studies indicate that a signif-
icant number of 1–3 subunits, which associate with 2
subunits, may also exist at extrasynaptic sites (Soltesz et al., 1990;
Nusser et al., 1998; Mangan et al., 2005; Thomas et al., 2005;
Kasugai et al., 2010). Although their functional significance re-
mains to be established in native systems, a recent study has pro-
posed that tonically active 132 receptors might contribute to
the clinical actions of positive allosteric modulators, such as eto-
midate and propofol (Li and Akk, 2015). Thus, the relative ex-
pression levels of extrasynaptic - and 2-containing receptors
may be important in determining the functional effects of com-
pounds, such as 4-PIOL, which can modulate both receptor iso-
forms under distinct conditions.
Low ambient GABA levels in neuronal preparations
Under our experimental conditions, the ambient GABA concen-
tration in all three neuronal preparations was estimated to be
significantly1 
M. In accord with these findings, although dif-
ficult to measure precisely in the structurally tortuous environ-
ment of the brain, microdialysis studies estimate that
extracellular GABA concentrations in vivo range from 30 nM to
2.9
M (Glaeser andHare, 1975; Lerma et al., 1986; deGroote and
Linthorst, 2007; Wlodarczyk et al., 2013), whereas the activity of
GABA transporters predicts that ambient GABA levels are within
0.1–0.4 
M (Attwell et al., 1993; Richerson andWu, 2003; Wu et
al., 2007).
Given the low ambient GABA levels that we estimate in slices,
and the low GABA sensitivity of 2 subunit-containing GABAA
receptors (Brown et al., 2002; Mortensen et al., 2010, 2011), it is
unsurprising that the extrasynaptic population of 2-containing
receptors, detected in dLGN relay neurons, did not significantly
contribute to basal tonic currents under our experimental condi-
tions. However, this does not discount the possibility that 2-
containing receptors may contribute to tonic currents when
ambient GABA levels are significantly increased, for instance,
during behavioral or pathophysiological disease states. Although
applying diazepam to dLGN relay neurons enhanced dLGN tonic
currents, demonstrating that 2-containing receptors can con-
tribute to tonic currents, it is difficult to discount the possibility
that diazepam may have increased the apparent affinity of these
receptors for GABA (Gielen et al., 2012), thus recruiting a popu-
lation of extrasynaptic 2-containing receptors that may be inac-
tive under control conditions.
The observation that ambient GABA levels strongly influ-
ence the functional profile of 4-PIOL is unsurprising given
that both 4-PIOL and GABA act via the same binding site.
Indeed, similar observations have been made for the agonist,
THIP, whose enhancement of -mediated tonic currents in
CGCs was attenuated at higher ambient GABA concentrations
(Houston et al., 2012). Thus, when evaluating the potential
effects of therapeutic compounds on tonic currents, an impor-
tant consideration is how this modulation will be affected by
variable ambient GABA concentrations.
Therapeutic potential of low-efficacy agonists
Overall, the therapeutic potential of a low-efficacy partial agonist,
such as 4-PIOL, has merit, but its action will critically depend on
a number of factors, including which GABAA receptor isoforms
are expressed, their expression levels on the cell surface, and am-
bient GABA levels. Given its enhancement of tonic currents at
low ambient GABA concentrations, a weak partial agonist like
4-PIOL might be most useful for neurological conditions where
an increased tonic inhibition is desirable, for example in Fragile X
syndrome and sleep disorders (Brickley and Mody, 2012; Whis-
sell et al., 2015).
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